How have companies in the multiplatform molecular biology tools sector grown revenues for the three months ended Dec. 31? If you're one of the top performers listed on the 15-company BioCommerce Week Index, you have one thing in common: You're been acquisitive over the past six months.

With the macro-economic environment improving, companies in this space are accelerating revenue growth with acquisitions, and, at least in the short term, this strategy is fattening their top lines.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.